ARA-290 - 16mg

ARA 290 is a next-generation peptide derived from erythropoietin (EPO) that delivers powerful anti-inflammatory, neuroprotective, and tissue-healing support—without stimulating excess red blood cell production. Expect faster recovery, calmer inflammation, nerve support, and better everyday performance.

Peptide Profile

• Peptide Name: ARA 290 (Cibinetide)
• CAS Number: 1208243-50-8
• Molecular Formula: C₅₁H₈₄N₁₆O₂₁
• Main Function: Anti-inflammatory, neuroprotective, tissue-regenerating peptide
• Mechanism of Action: Selectively engages the erythropoietin/CD131 “innate repair receptor” (IRR), activating protective and regenerative pathways without driving erythropoiesis.

Key Features & Benefits

• Helps reduce neuropathic pain and sensitivity
• Supports nerve regeneration and function
• Calms systemic inflammation and protects tissues
• Promotes wound healing and recovery after stress or training
• Supports kidney and cardiometabolic wellness
• Backed by human studies in small-fiber neuropathy and sarcoidosis-related symptoms
• Generally well-tolerated with a favorable safety profile

Best For: Individuals seeking relief from neuropathic discomfort, chronic inflammation, recovery support after injury or training, and overall wellness optimization.

Effects on Key Areas

• Blood Sugar & Metabolism: Supports healthy metabolic signaling.
• Muscle & Endurance: Aids post-training recovery and tissue repair.
• Joints & Tendons: Helps calm inflammatory stress and promote healing.
• Nervous System: Neuroprotective; supports small-fiber nerve health.
• Anti-Aging & Wellness: Cellular protection pathways that promote resilience.

Recommended Dosage & Administration

• Typical Range (research-based): 2–4 mg subcutaneously per day
• Cycle Length: Commonly 4 weeks; some protocols extend to 6–8 weeks depending on goals and response
• Dosing Tips: May be taken as a single daily dose or split AM/PM
• Administration: Subcutaneous injection; rotate sites to minimize irritation

The recommended dose of ARA 290 is between 3 mg and 4 mg per day (30–40 units), considering that one unit corresponds to 80 mcg. The duration of the cycle may vary depending on the specific health condition and individual needs, but it is generally taken for up to 2 months.

Sample 6-Week Plan

1. Weeks 1–2: 2 mg daily (assess tolerance and response)
2. Weeks 3–6: 3–4 mg daily (adjust within 2–6 mg/day as needed)

After completion, take a short break; cycles may be repeated based on goals.

What Is ARA 290?

ARA 290 (Cibinetide) is a synthetic, non-erythropoietic analog inspired by the helix-B region of EPO. It targets the innate repair receptor (IRR) to switch on built-in protective programs—reducing inflammation, shielding nerves from damage, and accelerating natural repair without raising hematocrit.

Benefits

• Injury and tissue healing support
• Joint and tendon comfort during training blocks
• Neuroprotection for small-fiber nerves
• Systemic anti-inflammatory support
• Bone and muscle recovery after high workloads
• Improved endurance recovery and performance
• Healthy aging and overall wellness reinforcement

Clinical Trials & Research

• Small-Fiber Neuropathy (Sarcoidosis): Daily subcutaneous ARA 290 over ~4 weeks improved neuropathic symptoms, small-fiber nerve density, sensory thresholds, and exercise capacity.
• Neuropathic Pain & Quality of Life: Human studies report reductions in pain scores and gains in physical functioning and well-being.
• Broader Potential: Early research suggests tissue-protective and metabolic benefits; larger trials are ongoing.

Applications in Sports & Fitness

• Accelerated recovery after hard training
• Tendon and joint comfort through inflammation control
• Neural support for consistent performance
• Tissue-repair support during high-volume phases

Possible Side Effects

• Mild, temporary injection-site discomfort
• Infrequent, transient changes in blood pressure or blood sugar
• Rare hypersensitivity reactions (rash, swelling, breathing difficulty)

Conclusion

ARA 290 (Cibinetide) delivers a high-value combination of inflammation control, nerve protection, and repair support. It’s a smart choice for athletes and high performers looking to reduce pain, recover faster, and elevate wellness—confident, clean, and targeted.

FAQs

• What is ARA 290? A non-erythropoietic EPO-derived peptide that reduces inflammation, protects nerves, and promotes tissue healing.
• What are the key benefits? Reduced neuropathic pain, calmer inflammation, supported nerve function, faster recovery.
• Who can use it? Active individuals and high performers seeking nerve, joint, and recovery support.
• How do I take it? Subcutaneous injection once daily (or split), typically 2–6 mg/day for ~4–6 weeks.
• Are there side effects? Mostly mild and temporary; rare allergic responses possible.
• Is it legal? Regulatory status varies; check local guidelines.
• Why choose Nordic Peptides? Premium purity, consistent potency, performance-driven results.

Ready to accelerate recovery and protect your nerves? Order Nordic Peptides ARA 290 (Cibinetide) today and feel the difference in performance and wellness.